YTHDF2 and hepatocellular carcinoma: These findings were consistent with the previous studies that NVP‐AUY922 can attenuate drug resistance in diverse models.[23] Moreover, the protein expression and correlation of HSP90β, YTHDF2, and STUB1 were also verified in the clinical samples derived from HCC patients.